Antibody Status Impacts Disease Severity in MG
Patients with myasthenia gravis (MG) who are positive for a combination of both anti-acetylcholine receptor (AChR) and anti-Titin antibodies (AChR+Titin-MG) had more severe symptoms and progressed faster than patients with only anti-AChR (AChR-MG), and those with anti-AChR in combination with anti-low-density lipoprotein receptor-related protein 4 (LRP4) antibodies (AChR+LRP-MG), as published in Frontiers in Neurology. Patients…